BetalasEN: Microdilution Panel for Identifying Beta-lactamases Present in Isolates of Enterobacteriaceae

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2002 Jan 5

PMID 11773104

Authors

Christine C. Sanders

Anton F Ehrhardt

Ellen Smith Moland

Kenneth S Thomson

Barbara Zimmer

Darcie E Roe

Affiliations

Soon will be listed here.

Abstract

A dried investigational use-only microdilution panel named betalasEN (a short named derived from the panel's purpose, to identify beta-lactamases in Enterobacteriaceae) containing 10 beta-lactam drugs with and without beta-lactamase inhibitors was developed to identify beta-lactamases among clinical isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Citrobacter koseri, Citrobacter freundii group, Enterobacter spp., and Serratia marcescens. The MICs obtained with a collection of 383 organisms containing well-characterized beta-lactamases were used to develop numeric codes and logic pathways for computerized analysis of results. The resultant logic pathways and betalasEN panel were then used to test and identify beta-lactamases among 885 isolates of Enterobacteriaceae recovered in cultures obtained at six different hospital laboratories across the United States. beta-Lactamases present in 801 (90.5%) of the 885 isolates were identified by betalasEN by using the existing logic pathways and codes or after minor modifications were made to the existing codes. The 84 strains that gave codes that betalasEN could not identify were collected, reidentified, and retested by using betalasEN. Three strains had been misidentified, 54 strains gave different codes upon repeat testing that could be identified by betalasEN, and 27 strains repeated new codes. The beta-lactamases in these strains were identified, and the new codes were added to the betalasEN logic pathways. These results indicate that betalasEN can identify clinically important beta-lactamases among most isolates of Enterobacteriaceae. The results also show that good quality control and attention to proper performance of the tests are essential to the correct performance of betalasEN.

References

Ehrhardt A, Sanders C, Moland E . Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae. Antimicrob Agents Chemother. 1999; 43(3):630-3. PMC: 89171. DOI: 10.1128/AAC.43.3.630. View

Gazouli M, Tzouvelekis L, Prinarakis E, Miriagou V, Tzelepi E . Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2). Antimicrob Agents Chemother. 1996; 40(7):1736-40. PMC: 163408. DOI: 10.1128/AAC.40.7.1736. View

Casellas J, Goldberg M . Incidence of strains producing extended spectrum beta-lactamases in Argentina. Infection. 1989; 17(6):434-6. DOI: 10.1007/BF01645567. View

OCALLAGHAN C, Muggleton P, Ross G . Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob Agents Chemother (Bethesda). 1968; 8:57-63. View

Jarlier V, Nicolas M, Fournier G, Philippon A . Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10(4):867-78. DOI: 10.1093/clinids/10.4.867. View

Bush K, Jacoby G, Medeiros A . A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6):1211-33. PMC: 162717. DOI: 10.1128/AAC.39.6.1211. View

Jacoby G, Medeiros A . More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991; 35(9):1697-704. PMC: 245253. DOI: 10.1128/AAC.35.9.1697. View

Gazouli M, Tzelepi E, Sidorenko S, Tzouvelekis L . Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis. Antimicrob Agents Chemother. 1998; 42(5):1259-62. PMC: 105797. DOI: 10.1128/AAC.42.5.1259. View

Bauernfeind A, Chong Y, Lee K . Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?. Yonsei Med J. 1999; 39(6):520-5. DOI: 10.3349/ymj.1998.39.6.520. View

10.

Bradford P, Urban C, Mariano N, Projan S, Rahal J, Bush K . Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother. 1997; 41(3):563-9. PMC: 163751. DOI: 10.1128/AAC.41.3.563. View

11.

Coudron P, Moland E, Sanders C . Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol. 1997; 35(10):2593-7. PMC: 230016. DOI: 10.1128/jcm.35.10.2593-2597.1997. View

12.

Ho P, Chow K, Yuen K, Ng W, Chau P . Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother. 1998; 42(1):49-54. DOI: 10.1093/jac/42.1.49. View

13.

Petit A, Sofer L, Labia R . Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?. FEMS Microbiol Lett. 1992; 71(1):89-94. DOI: 10.1016/0378-1097(92)90547-2. View

14.

Mathew A, Harris A, Marshall M, Ross G . The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol. 1975; 88(1):169-78. DOI: 10.1099/00221287-88-1-169. View

15.

Sanders C, Watanakunakorn C . Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. J Infect Dis. 1986; 153(3):617-9. DOI: 10.1093/infdis/153.3.617. View

16.

Ohara K, Haruta S, Sawai T, Tsunoda M, Iyobe S . Novel metallo beta-lactamase mediated by a Shigella flexneri plasmid. FEMS Microbiol Lett. 1998; 162(2):201-6. DOI: 10.1111/j.1574-6968.1998.tb12999.x. View

17.

Thomson K, Sanders C . Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother. 1992; 36(9):1877-82. PMC: 192203. DOI: 10.1128/AAC.36.9.1877. View

18.

Sanders C, Barry A, Washington J, Shubert C, Moland E, Traczewski M . Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. J Clin Microbiol. 1996; 34(12):2997-3001. PMC: 229448. DOI: 10.1128/jcm.34.12.2997-3001.1996. View

19.

Lauretti L, Riccio M, Mazzariol A, Cornaglia G, Amicosante G, Fontana R . Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999; 43(7):1584-90. PMC: 89328. DOI: 10.1128/AAC.43.7.1584. View

20.

Bakken J, Sanders C, Thomson K . Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein. J Infect Dis. 1987; 155(6):1220-5. DOI: 10.1093/infdis/155.6.1220. View